Related references
Note: Only part of the references are listed.Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis
Jian-Bo Xu et al.
HEPATOLOGY RESEARCH (2014)
HCV direct-acting antiviral agents: the best interferon-free combinations
Raymond Schinazi et al.
LIVER INTERNATIONAL (2014)
Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection
Yoshisato Tanimoto et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma
Hirokazu Miyatake et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
Masayuki Sakae et al.
HEPATOLOGY RESEARCH (2012)
Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma
Soji Shimomura et al.
HEPATOLOGY INTERNATIONAL (2011)
Cancer preventive effect of pegylated interferon α-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis
Sumio Watanabe et al.
HEPATOLOGY RESEARCH (2011)
Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
Hiroaki Hagihara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy
Yuko Nagaoki et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
Y. Miyake et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Impact of Interferon Therapy after Curative Treatment of Hepatocellular Carcinoma
Masatoshi Kudo
ONCOLOGY (2008)
Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation
Masatoshi Kudo et al.
ONCOLOGY (2007)
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Vincenzo Mazzaferro et al.
HEPATOLOGY (2006)
Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma
Takahiro Uenishi et al.
HEPATOLOGY RESEARCH (2006)
Growth inhibitory effects of pegylated IFN α-2b on human liver cancer cells in vitro and in vivo
Hirohisa Yano et al.
LIVER INTERNATIONAL (2006)
Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma - Updated analysis of the long-term follow-up data
K Takai et al.
INTERVIROLOGY (2005)
Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma
Y Sakaguchi et al.
INTERVIROLOGY (2005)
Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2005)
Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma
S Nishiguchi et al.
INTERVIROLOGY (2005)
Adherence to combination therapy enhances sustained response in genotyp-1-infected patients with chronic hepatitis C
JG McHutchison et al.
GASTROENTEROLOGY (2002)
Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma -: A randomized, controlled trial
S Kubo et al.
ANNALS OF INTERNAL MEDICINE (2001)
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer
K Ikeda et al.
HEPATOLOGY (2000)